Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

OP Finnfund Global Impact Fund I invests in Sathapana Bank, Cambodia, to accelerate SME growth and women empowerment

OP Finnfund Global Impact Fund I, the first global emerging markets impact fund in Finland, invests USD 10 million in Sathapana Bank , one of Cambodia’s largest banks, aiming to accelerate the development of small and medium-sized enterprises (SMEs) and women empowerment. The funding provided by OP Finnfund Global Impact Fund I will allow Sathapana to broaden its client base and grant more loans to its existing clients, including the women segment. Born in 2016 with the merger of two institutions, Maruhan Japan Bank and Sathapana Limited, Sathapana Bank has

Risk Intelligence A/S Q3 revenue up by 19% and System ARR growth of 24%

Risk Intelligence A/S (“Risk Intelligence” or “the Company”) reports 19% growth in revenue in Q3 2021 compared to Q3 2020 and 20% growth for the nine months period 2021 compared to 2020. The Company’s System ARR increased by 24% during Q3 2021.Risk Intelligence has increased revenue in Q3 2021 by 19% (4,230,747 DKK) compared to Q3 2020 (3,114,299 DKK). Subsequently, revenue in the nine months period of 2021 increased by 20% (DKK 11,292,810) compared to 2020 (DKK 9,040,281). Q3 boosted by growth in orders and in sizeThe 19% growth in Q3 was mainly a combination of new license agreements

Sectra and major private care provider Unilabs extend cooperation with a new radiology imaging contract in Portugal

Linköping, Sweden – October 6, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a three-year contract with Unilabs in Portugal to deliver the radiology module of Sectra’s enterprise imaging solution. The platform will provide radiologists with efficient workflow capabilities and allow radiologists across the Unilabs organization in Portugal to cooperate efficiently around patients.“We are a distributed and growing healthcare provider with the quality of our clinical results as our foremost priority. Given the

The Pathways Coalition welcomes PostNord

PostNord has become the first logistics operator to be elected to join The Pathways Coalition, a partnership devoted to accelerating the transition to sustainable transport solutions. The ultimate aim is to establish conditions for the historically rapid transition that is required to ensure a fossil-free commercial transport system no later than 2050.Transport is the second-largest source of global carbon emissions. This means that in order to achieve the climate targets set out in the Paris Agreement, heavy transport operations have to become completely fossil-free. For this to be

Digitalisation of pumping stations – smart data-driven solution in hydropower condition monitoring

Caverion Industry Article 6 October 2021 at 10.00 a.m. EETDigitalisation of pumping stations – smart data-driven solution in hydropower condition monitoring Digitalisation, analytics and remote monitoring already play an important role in maintenance, but even more so in the future. In industrial condition monitoring, all this becomes increasingly important as different data collection methods are introduced, the available data is crushed and utilised in the maintenance of different production environments. Kemijoki Oy is the most important producer of hydropower and

24SevenOffice acquires Smartbob AS

Smartbob AS has developed Prisolve, a 100% cloud based financial reporting system which is already integrated with 24SevenOffice. The software allows customers to do advanced financial reporting and is tailored for accounting firms, auditors and managers including CFOs. The reporting system is flexible and customizable to fit each customer's specific requirements as well as having several reporting templates, including regulatory reporting for accounting firms.  Smartbob AS has four employees and revenues in 2021 is expected to be around 5 MSEK with marginally positive EBITDA.

BioStock: Positive results for RhoVac in 3-year follow-up of phase I/II-study

The results speak for themselves when RhoVac presents its follow-up of the phase I/II study conducted three years ago at Rigshospitalet in Copenhagen. No metastases, no indication of a need for further treatment in order to maintain immunity, and no indication of significant development of PSA in treated patients. This is great news for the company, says CEO Anders Månsson when BioStock contacts him.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/positive-results-for-rhovac-in-3-year-follow-up-of-phase-i-ii-study/This is a press release from BioStock - Connecting

BioStock: Ultimovacs enters next step in new vaccine platform development

Ultimovacs’ TENDU trial is a clinical phase I study aimed at testing the company’s TET platform for cancer vaccine development in prostate cancer patients. The study was initiated earlier this year with the first cohort of patients; now the company has announced dosing the first patient in the second of three cohorts for the TENDU study.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/ultimovacs-enters-next-step-in-new-vaccine-platform-development-2/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Ultimovacs enters next step in new vaccine platform development

Ultimovacs’ TENDU trial is a clinical phase I study aimed at testing the company’s TET platform for cancer vaccine development in prostate cancer patients. The study was initiated earlier this year with the first cohort of patients; now the company has announced dosing the first patient in the second of three cohorts for the TENDU study.Read the full article at biostock.se: https://www.biostock.se/en/2021/10/ultimovacs-enters-next-step-in-new-vaccine-platform-development-2/ This is a press release from BioStock - Connecting Innovation & Capital.

Genovis AB (publ.) hires new CFO

Genovis has hired Magnus Långberg as the new CFO of the Group; he will begin in January 2022.Magnus Långberg has over 20 years of experience from a variety of positions within finance and management at international life science companies. He will be joining Genovis from his most recent position at Hemocue AB. Before that he worked at companies such as QPharma and BD Medical. “I’m pleased to be able to welcome Magnus Långberg as the new CFO of Genovis. Magnus will have an important role in Genovis’ continued development and I look forward to working with him,” says Fredrik Olsson, CEO of

Evolution and Betway strengthen partnership in the US

Evolution has announced that it has signed an agreement with Super Group owned Betway for the provision of Evolution’s online Live Casino and ‘First Person’ RNG-based casino games in the US states of New Jersey and Pennsylvania.Betway is a globally recognised online betting and gaming brand and is a long-standing Evolution customer. Betway has entered the US market through an exclusive brand licensing agreement with Digital Gaming Corporation (DGC). The Evolution-Betway deal will see Evolution online Live Casino games and ‘First Person’ RNG-casino games made available to Betway players

Evolution´s Nomination Committee for the 2022 Annual General Meeting

In accordance with the resolution of the Annual General Meeting, the three largest shareholders in the company as per the last business day of August who wish to appoint a representative shall appoint the Nomination Committee. If any of these shareholders chooses to waive their right to elect a representative, their right is transferred to the shareholder who, after these shareholders, has the largest share ownership and wishes to use this right. In addition, a member of the Board of Directors who is independent in relation to the company’s management shall be a member of the Nomination

Nobina to expand in Norrbotten under new contract

Under a new contract commencing in June 2022, Nobina has been awarded an expanded assignment by Länstrafiken i Norrbotten to operate and develop services on the main route between Boden and Luleå. The contract, which will be Nobina’s fourth in Region Norrbotten and third in collaboration with Länstrafiken i Norrbotten, is valued at approximately SEK 50 million over a contract period of two years. No additional optional years are included.The new contract entails that Nobina will continue to expand its operations in Norrbotten, which currently comprise services in, for example, Piteå,

Skanska invests NOK 210M, about SEK 210M in a residential development property in Bærum, Norway

Skanska has acquired a development property in Bærum, Norway.  The net investment for residential purpose amounts to NOK 210M, about SEK 210M. The seller is Profier.The property Kirkeveien 59 is ready zoned for block housing and concentrated single-family housing. Skanska plans to build 50 apartments and 28 terraced houses. The project will be BREEAM-certified and construction work is expected to start 2023. Skanska is one of the leading construction- and project development companies in the Nordics, with operations in building construction and civil engineering in Sweden, Norway and

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 5th October 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 25,914,214 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Fabege acquires SHH Bostad AB

SHH is a real estate development company with a focus on residential and local authority properties. Fabege’s strategy of optimising the value of its residential development rights portfolio is thereby being reinforced by the company acquiring both expertise and more development rights in its home market of Stockholm. All the shares in SHH are being acquired for a purchase price of SEK 880m. As of 18 October, SHH will be a wholly owned subsidiary of Fabege.SHH was founded in 2010 and has since completed over 40 real estate projects, with approximately 2,100 homes. At mid-year 2021, SHH had

Ocean Yield ASA: Commencement of offer period for recommended voluntary cash offer for all outstanding shares of Ocean Yield ASA at NOK 41 per share

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Oslo, 6 October 2021 – Reference is made to the announcement on 13 September 2021 regarding an offer to acquire all outstanding shares of Ocean Yield ASA ("Ocean Yield" or the "Company") and the Oslo Stock Exchange's announcement of approval of the offer document dated 5 October 2021 (the "Offer Document"). Octopus Bidco AS (the "Offeror"), a

AlzeCure Pharma develops novel analgesic drug based on Nobel prize-winning discoveries

Stockholm, Sweden, October 6, 2021. AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the its novel clinical candidate drug ACD440 for peripheral neuropathic pain, is based on the seminal discoveries of TRPV1 by Prof. Julius, and for which he was awarded the Nobel Prize in Medicine 2021.David Julius, PhD, professor and chair of the Department of Physiology and Morris Herzstein Chair in Molecular

First day of trading in Storskogen’s B-shares on Nasdaq Stockholm

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. Neither this announcement, nor anything contained herein, shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any securities referred to in this announcement except on the basis of information contained in a prospectus in its final form (the “Prospectus”) that has been

New EU tire labels help drivers – especially useful for online shoppers

Europe has become the first region in the world to start using an ice grip symbol for tires. A snow grip symbol and QR code leading to a massive database have also been added to the tires. The new symbols help consumers to compare different alternatives and to choose safe tires that reduce emissions. As a winter tire pioneer, Nokian Tyres  has long advocated for developing the labels.  Tire labels are being renewed across the entire EU. New labels are required on tires manufactured after May 1, 2021, so the new labels will start gradually appearing on tires

Handelsbanken’s interim report for January –September 2021 will be presented on Wednesday, 20 October

Handelsbanken publishes its interim report for January ­– September 2021 at 6:30 a.m. CET on Wednesday, 20 October. The Group Chief Executive Carina Åkerström will present the Bank’s interim report at 8:30 a.m. CET. at a meeting with the media and analysts, at Handelsbanken’s head office, Kungsträdgårdsgatan 2, Stockholm. The presentation will be held in Swedish, with simultaneous interpretation into English. A link to the presentation will be available at handelsbanken.com/ir. Registration in advance is required, please send your notification of your intention to attend, by email to

Invitation to presentation of Hexagon's Interim Report on 28 October

Hexagon will release its Interim Report for the third quarter 2021 on Thursday 28 October at approximately 08:00 CET. A combined telephone conference and live webcast concerning the report will be presented by President and CEO Ola Rollén on the same day at 10:00 CET. Please call +46 (0) 8 566 426 51 (SWE), +44 (0) 333 300 0804 (UK), +1 631 913 1422 (US) (code: 24159039#) to participate in the telephone conference or visit hexagon.com to access the webcast. The presentation material will also be available for viewing on the Company’s website on-demand. For further information,

Stille to Launch a New General Surgery Table

Stille AB (publ) announces exclusive collaboration with GE Healthcare for a new general surgery table in the United States.The new general surgery table, GS2®, has been developed to address a growing need for a premium general surgery table that satisfies the needs of multi-disciplinary surgery units such as Ambulatory Surgery Centers (ASC), while also providing a cost effective high-value solution. These healthcare facilities perform procedures across a wide spectrum of surgical disciplines alongside the OEC C-arms such as orthopedics, general surgery, cardiovascular, and urology, as well

There are no items matching the current filter
There are no more items matching the current filter
Back to top